Literature DB >> 3392058

Treatment of the cervical spine in rheumatoid arthritis.

S Santavirta1, P Slätis, U Kankaanpää, J Sandelin, E Laasonen.   

Abstract

Of thirty-four selected patients who had rheumatoid arthritis and subluxations of the atlanto-axial and other joints of the cervical spine, eighteen were treated operatively and sixteen were treated non-operatively. Of the subluxations of the atlanto-axial joint, nineteen were anterior; four, posterior; and eleven, vertical. Additionally, subaxial subluxations were seen in three patients. At the time of treatment, the mean duration of the rheumatoid disease was 19.4 years and the mean duration of the disorders of the cervical spine was 4.5 years. After treatment the patients were followed for an average of 2.2 years (range, six months to six years). Of the thirty-four patients, two (both of whom were treated non-operatively) died of causes unrelated to the lesions of the cervical spine and were excluded from this study. Of the remaining thirty-two patients, eighteen were treated operatively and fourteen, non-operatively. The two groups were roughly comparable with respect to the lesions of the cervical spine, but more of the patients who were treated surgically showed evidence of compression of the cord as demonstrated by computed tomography and myelography. The thirty-two patients were not randomized in the two groups; therefore, comparison of the findings in these groups is not completely valid. Surgical treatment of the eighteen patients included an atlanto-axial fusion in thirteen and an occipitocervical fusion in five. In addition, two patients who had an occipitocervical fusion also had a subaxial laminectomy and posterior fusion. There was a superficial wound infection, which was treated successfully with short-term antibiotic therapy, in two patients. No patient died postoperatively. Occipital pain was relieved in twelve of the fifteen operatively treated patients who had pain, whereas pain was relieved in only one of the eight conservatively treated patients who had pain. At follow-up, neurological function was unchanged or improved in the operatively treated group but was slightly worse in the conservatively treated group. We concluded that fusion of an unstable rheumatoid cervical spine relieves pain and prevents progression of existing neural lessons without undue risk for the patient.

Entities:  

Mesh:

Year:  1988        PMID: 3392058

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  7 in total

1.  Improved medical and surgical management of cervical spine disease in patients with rheumatoid arthritis over 10 years.

Authors:  J D Hamilton; M M Gordon; I B McInnes; R A Johnston; R Madhok; H A Capell
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

2.  The importance of functional magnetic resonance imaging (MRI) in the planning of stabilizing operations on the cervical spine in rheumatoid patients.

Authors:  A Krödel; H J Refior; S Westermann
Journal:  Arch Orthop Trauma Surg       Date:  1990       Impact factor: 3.067

Review 3.  Cervical spine instability in rheumatoid arthritis.

Authors:  Filipa Camacho da Côrte; Nuno Neves
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-06-27

4.  Outcome of cervical spine surgery in patients with rheumatoid arthritis.

Authors:  K M van Asselt; W F Lems; E B Bongartz; H L Hamburger; K W Drossaers-Bakker; B A Dijkmans; R M van Soesbergen
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

Review 5.  [Cervical myelopathy as a complication of rheumatoid arthritis].

Authors:  A C Arlt; J Steinmetz
Journal:  Z Rheumatol       Date:  2004-08       Impact factor: 1.372

Review 6.  Advances in the treatment of cervical rheumatoid: Less surgery and less morbidity.

Authors:  Grant W Mallory; Sasha R Halasz; Michelle J Clarke
Journal:  World J Orthop       Date:  2014-07-18

Review 7.  Rheumatoid cervical joint disease--a challenge to the anaesthetist.

Authors:  A Macarthur; S Kleiman
Journal:  Can J Anaesth       Date:  1993-02       Impact factor: 5.063

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.